tenocyclidine has been researched along with mdl 105519 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baron, BM; Fadayel, GM; Harrison, BL; Kehne, JH; McCloskey, TC; Murawsky, MK; Nyce, P; Salituro, FG; Schmidt, CJ; Senyah, Y; Siegel, BW; Taylor, VL; van Giersbergen, PL; White, HS | 1 |
1 other study(ies) available for tenocyclidine and mdl 105519
Article | Year |
---|---|
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Calcium Channels; Cells, Cultured; Cerebellum; Cyclic GMP; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Indoles; Ligands; Male; Mice; Mice, Inbred DBA; Motor Activity; N-Methylaspartate; Phencyclidine; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Sodium Channels | 1997 |